Signal sequence that induces protein secretion in intestinal microbiome
US-2024190925-A1 · Jun 13, 2024 · US
US9815870B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9815870-B2 |
| Application number | US-201414764727-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 30, 2014 |
| Priority date | Jan 30, 2013 |
| Publication date | Nov 14, 2017 |
| Grant date | Nov 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention described herein features variants related to infrared fluorescent proteins, in particular to mutants of a phytochrome from the bacterium Bradyrhizobium sp. ORS278. The variants show approximately a ten-fold increase in brightness compared to other known infrared fluorescent proteins. The variants are monomeric, allowing them to be used as a protein tag without disrupting the function of the tagged protein of interest.
Opening claim text (preview).
We claim: 1. A variant polypeptide of a parent polypeptide, wherein said variant polypeptide comprises at least 90% identity to SEQ ID NO:2, wherein the variant polypeptide comprises at least one amino acid substitution at a position selected from the group consisting of position 2, 8, 14, 74, 107, 128, 146, 156, 168, 175, 178, 185, 199, 210, 256, 258, 292, 310, and 320, wherein the numbering of the amino acid positions correspond to that in native BrBphP from Bradyrhizobium sp. ORS278, and wherein the variant polypeptide is an infrared fluorescent polypeptide. 2. The variant polypeptide of claim 1 , wherein said variant polypeptide comprises at least 95% identity to SEQ ID NO:2. 3. The variant polypeptide of claim 1 , wherein said variant polypeptide comprises SEQ ID NO:2. 4. The variant polypeptide of claim 1 , wherein the variant polypeptide comprises at least one amino acid substitution selected from the group consisting of 2S, 8S, 14F, 74P, 107I, 128I, 146 M, 156I, 168 V, 175N, 178I, 185 A, 199T, 210H, 256M, 258D, 292H, 310T, and 320K. 5. The variant polypeptide of claim 4 , wherein the variant polypeptide comprises the amino acid substitutions 2S, 8S, 14F, 74P, 107I, 128I, 146 M, 156I, 168V, 175N, 178I, 185A, 199T, 210H, 256M, 258D, 292H, 310T, and 320K. 6. The variant polypeptide of claim 1 , wherein the variant polypeptide further comprises amino acid substitution I251C. 7. The variant polypeptide of claim 1 , wherein the polypeptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOS: 10, 12, 14, 16, 18, 20, 22, 24, and 26.
Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)} · CPC title
Fusion polypeptide · CPC title
from bacteria · CPC title
the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.